Clinical Trial

Pola-ZR2P in Previously Untreated DLBCL

Name: Pola-ZR2P in Previously Untreated DLBCL — clinical trial record (NCT06664411)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this phase 2 trial is to test the safety and efficacy of Pola-ZR2P as induction therapy in patients with DLBCL.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-10-27.

Status change: Not Yet Recruiting → Recruiting 2025-08-13

Trial Details

NCT Number	NCT06664411
Lead Sponsor	Navy General Hospital, Beijing
Conditions	Diffuse Large B-cell Lymphoma
Enrollment	80 participants
Start Date	2024-09-24
Primary Completion	2029-12 (estimated)
Study Completion	2030-12 (estimated)
Updated on ClinicalTrials.gov	2025-08-19